Abstract
In order to administer antipsychotic medication with the most beneficial outcome, the appropriate drug and dose needs to be identified. Though often not considered in pharmacogenetic studies, dosage plays an important role in treatment outcome. This study set out to analyze the association between 109 SNPs and antipsychotic dosage among schizophrenia patients. In a previous study, we tested 134 SNPs in regards to antipsychotic dosage. In the current study, we tested additional markers in the same candidate genes that we investigated in the previous study to confirm our previous findings. We included 263 participants with schizophrenia spectrum disorders between the ages of 18-75. Each participant was assessed cross-sectionally to collect clinical and antipsychotic treatment information through a semi-structured interview. The antipsychotic dosage for each individual was standardized according to chlorpromazine equivalents (CPZe), defined daily dose, and the percentage of maximum dosage (PM%). For each participant, 109 SNPs from 29 candidate genes were imputed or genotyped using a Customized Illumina Chip. Polymorphisms in the GABRB1 gene were significantly associated with higher antipsychotic dosage according to CPZe and PM% st...Continue Reading
References
Jul 4, 1998·Brain Research. Brain Research Reviews·P SomogyiE H Buhl
Mar 30, 2000·The American Journal of Psychiatry·S KapurS Houle
Jul 25, 2000·Journal of Clinical Pharmacy and Therapeutics·N PoolsupT L Knight
Dec 18, 2001·Biological Psychiatry·S Kapur, G Remington
Dec 10, 2003·Archives of General Psychiatry·Ofer AgidRobert B Zipursky
Jul 9, 2009·Pharmacopsychiatry·D SuarezD Naber
Jul 28, 2009·Neuropharmacology·Erik I CharychNicholas J Brandon
Apr 3, 2010·The American Journal of Psychiatry·David M GardnerRoss J Baldessarini
Jun 29, 2010·European Journal of Clinical Pharmacology·Guillermo GervasiniJuan Antonio Carrillo
Sep 10, 2011·Neural Plasticity·Guillermo Gonzalez-BurgosDavid A Lewis
Apr 24, 2012·Psychiatry Research·Eric Hermes, Robert Rosenheck
Jul 28, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia
Nov 7, 2012·Handbook of Experimental Pharmacology·Nathalie Ginovart, Shitij Kapur
Jul 23, 2013·Schizophrenia Research·Dana RavynHenry A Nasrallah
Jul 13, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Nuwan C HettigeVincenzo De Luca
Dec 9, 2014·Biological Psychiatry·Steven P Hamilton
Citations
Mar 13, 2018·Current Opinion in Psychiatry·Clement C ZaiJames L Kennedy
Oct 2, 2020·Molecular Medicine Reports·Xu YouYong Zeng
Oct 4, 2021·Chinese Medicine·Xian ZhangFan Qu